BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17049892)

  • 1. Pattern recognition methods investigation of ellipticines structure-activity relationships.
    de Melo LC; Braga SF; Barone PM
    J Mol Graph Model; 2007 Mar; 25(6):912-20. PubMed ID: 17049892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzo[c]quinolizin-3-ones theoretical investigation: SAR analysis and application to nontested compounds.
    Braga SF; Galvão DS
    J Chem Inf Comput Sci; 2004; 44(6):1987-97. PubMed ID: 15554668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structure-activity study of taxol, taxotere, and derivatives using the electronic indices methodology (EIM).
    Braga SF; Galvão DS
    J Chem Inf Comput Sci; 2003; 43(2):699-706. PubMed ID: 12653540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship].
    Fossé P; Charra M; Paoletti C; Saucier JM; René B
    Bull Cancer; 1994 Mar; 81(3):194-202. PubMed ID: 7894127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structure-activity relationship study of quinone compounds with trypanocidal activity.
    Molfetta FA; Bruni AT; Honório KM; da Silva AB
    Eur J Med Chem; 2005 Apr; 40(4):329-38. PubMed ID: 15804532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA binding ellipticine analogues: synthesis, biological evaluation, and structure-activity relationships.
    Ferlin MG; Marzano C; Gandin V; Dall'Acqua S; Dalla Via L
    ChemMedChem; 2009 Mar; 4(3):363-77. PubMed ID: 19197924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chemometric study of megazol derivatives with activity against Trypanosoma equiperdum.
    Rosselli FP; Albuquerque CN; Da Silva AB
    SAR QSAR Environ Res; 2006 Dec; 17(6):533-47. PubMed ID: 17162385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivities and Action Mechanisms of Ellipticine Derivatives Reported Prior to 2023.
    Hou W; Xu XL; Huang LJ; Zhang ZY; Zhou ZN; Wang JY; Ouyang X; Xin SY; Zhang ZY; Xiong Y; Huang H; Lan JX
    Chem Biodivers; 2024 May; 21(5):e202400210. PubMed ID: 38433548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analogues.
    Shi LM; Fan Y; Myers TG; O'Connor PM; Paull KD; Friend SH; Weinstein JN
    J Chem Inf Comput Sci; 1998; 38(2):189-99. PubMed ID: 9538518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
    Nandi S; Vracko M; Bagchi MC
    Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticancer agent ellipticine unwinds DNA by intercalative binding in an orientation parallel to base pairs.
    Canals A; Purciolas M; Aymamí J; Coll M
    Acta Crystallogr D Biol Crystallogr; 2005 Jul; 61(Pt 7):1009-12. PubMed ID: 15983425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic and antitumoral properties in a series of new, ring D modified, olivacine analogues.
    Guillonneau C; Nault A; Raimbaud E; Léonce S; Kraus-Berthier L; Pierré A; Goldstein S
    Bioorg Med Chem; 2005 Jan; 13(1):175-84. PubMed ID: 15582462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on the antipicornavirus activity of flavonoid compounds (flavones) by using quantum chemical and chemometric methods.
    Souza J; Molfetta FA; Honório KM; Santos RH; da Silva AB
    J Chem Inf Comput Sci; 2004; 44(3):1153-61. PubMed ID: 15154785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise synthesis and antiproliferative activity evaluation of ellipticine quinone and its analogs.
    Nishiyama T; Hatae N; Mizutani M; Yoshimura T; Kitamura T; Miyano M; Fujii M; Satsuki N; Ishikura M; Hibino S; Choshi T
    Eur J Med Chem; 2017 Aug; 136():1-13. PubMed ID: 28477443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer simulations reveal a novel nucleotide-type binding orientation for ellipticine-based anticancer c-kit kinase inhibitors.
    Thompson D; Miller C; McCarthy FO
    Biochemistry; 2008 Sep; 47(39):10333-44. PubMed ID: 18754682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stacking interactions between demethylated ellipticines and DNA base pairs--a quantum mechanical study.
    Sanyal NK; Roychoudhury M; Tiwari SN
    Indian J Biochem Biophys; 1990 Aug; 27(4):222-7. PubMed ID: 2286387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between Molecular Complexity, Biological Activity, and Structural Diversity.
    Schuffenhauer A; Brown N; Selzer P; Ertl P; Jacoby E
    J Chem Inf Model; 2006; 46(2):525-35. PubMed ID: 16562980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticancer activity of new 1-substituted-6H-pyrido[4,3-b]carbazole derivatives.
    Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Wietrzyk J
    Arch Pharm (Weinheim); 2008 Jun; 341(6):351-6. PubMed ID: 18404778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-activity relationship analysis of 4-trifluoromethylimidazole derivatives with the concept of absolute hardness.
    Ishihara M; Kawase M; Sakagami H
    Anticancer Res; 2007; 27(6B):4047-51. PubMed ID: 18225569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox parameters associated to cytotoxic and antitumor activities in the series of antitumor drugs ellipticines and derivatives.
    Auclair C
    Adv Exp Med Biol; 1990; 264():317-22. PubMed ID: 2244509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.